{"id":"NCT02856113","sponsor":"Takeda","briefTitle":"Phase 3 Alogliptin Pediatric Study","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared With Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10-14","primaryCompletion":"2021-08-06","completion":"2022-02-14","firstPosted":"2016-08-04","resultsPosted":"2022-10-19","lastUpdate":"2022-10-19"},"enrollment":152,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Alogliptin Benzoate","otherNames":["SYR-322","Nesina","Vipidia"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Alogliptin 25 mg","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to evaluate the efficacy of alogliptin 25 milligram (mg) once daily compared to placebo when administered as monotherapy, or when added onto a background of metformin alone, insulin alone, or a combination of metformin and insulin, as measured by the glycosylated hemoglobin (HbA1c) change from Baseline at Week 26 in pediatric participants with type 2 diabetes mellitus (T2DM).","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26","timeFrame":"Baseline and Week 26","effectByArm":[{"arm":"Placebo","deltaMin":-0.011,"sd":0.2809},{"arm":"Alogliptin 25 mg","deltaMin":0.091,"sd":0.2879}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.782"}]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":67,"countries":["United States","Brazil","Israel","Italy","Mexico","Poland","Russia"]},"refs":{"pmids":["40032809"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":76},"commonTop":["Headache","Hyperglycaemia","Diarrhoea","Vomiting","Influenza"]}}